登录

在线药房平台提供商Phlo完成900万英镑融资,以推动业务扩张

Phlo closes £9m investment round to fuel expansion

Digital Health | 2024-04-18 | 翻译由动脉网AI生成,点击反馈

可切换为仅中文


Phlo has closed a £9m growth investment round that will support it to significantly scale the business’s reach and service offering.The funding for the Glasgow-based company will help fuel its evolution from a digital pharmacy innovator to a leading UK digital healthcare company.This latest funding round follows on from the completion of Phlo’s £10m Series A raise 14 months ago, and a year on from the acquisition of the assets of former competitor, TruePill UK.

Phlo完成了一轮900万英镑的增长投资,将支持其大幅扩大业务范围和服务提供。这家总部位于格拉斯哥的公司的资金将有助于推动其从数字制药创新者向英国领先的数字医疗保健公司的发展。最近一轮融资是在14个月前完成Phlo 1000万英镑的A系列融资,以及一年前收购前竞争对手TruePill UK的资产之后进行的。

The round’s lead investor was Par Equity, who were joined by Thairm Bio and Scottish Enterprise – who also invested in the 2023 Series A.Phlo plans to expand its geographic footprint within the UK over the next 12 months, providing more patients with easier access to its growing range of digital healthcare services.

本轮的主要投资者是Par Equity,Thairm Bio和Scottish Enterprise也加入了该轮投资。他们还投资了2023年的A系列。Phlo计划在未来12个月内扩大其在英国的地理足迹,使更多患者更容易获得其不断增长的数字医疗保健服务。

This includes the NHS and private medication management service, Phlo Digital Pharmacy; the API-driven digital infrastructure platform for healthcare providers, Phlo Connect; and the recently launched Phlo Clinic, an on-demand treatment service.Paul Munn, managing partner at Par Equity, said: “We’re delighted to support Phlo in revolutionising the digital healthcare landscape as it continues on its journey of growth.”He added: “We’re excited to see the developments in Phlo’s next growth phase as we support them to scale across and become an end-to-end digital healthcare provider in the UK.”Phlo will also continue to expand its technology-based partnerships with both digital and traditional health providers.

这包括NHS和私人药物管理服务,Phlo数字药房;API驱动的医疗保健提供商数字基础设施平台Phlo Connect;最近推出的Phlo诊所是一项按需治疗服务。Par Equity管理合伙人保罗·穆恩(Paul Munn)表示:“我们很高兴支持Phlo在数字医疗领域进行革命性的变革,因为它将继续发展。”他补充道:“我们很高兴看到Phlo下一个增长阶段的发展,因为我们支持他们在英国扩大规模,成为一家端到端的数字医疗服务提供商。”Phlo还将继续扩大与数字和传统医疗服务提供商的技术合作伙伴关系。

It will also be focusing on improving and augmenting the technology stack services being delivered to existing partners.Nadeem Sarwar, founder and CEO of Phlo, said: “In the UK tech sector, the investment climate has been both unpredictable and incredibly challenging for the past two years. Despite.

它还将重点改进和扩大向现有合作伙伴提供的技术堆栈服务。Phlo创始人兼首席执行官纳迪姆·萨瓦尔(NadeeMSarwar)表示:“在英国科技领域,过去两年的投资环境既不可预测,又极具挑战性。

推荐阅读

机器人手术技术解决方案提供商Nami Surgical获得投资,将改革机器人辅助手术市场

businesswire 2024-05-08 19:05

微生物组治疗药物研发商EnteroBiotix完成2700万英镑融资,以推进临床试验

GlobeNewswire 2024-04-04 15:00

Carcinotech获得420万英镑融资

FinSMEs 2024-01-29 21:21

Digital Health

156篇

最近内容 查看更多

MHRA推出人工智能医疗设备监管沙盒

2 天前

互联健康技术平台提供商Careology与Evolent Health合作,为美国患者提供护理途径

2 天前

格洛斯特郡医院NHS FT推出DrDoctor患者门户网站

2024-05-15

相关公司查看更多

Phlo

在线药房平台提供商

立即沟通

相关机构查看更多

Thairm Bio

医疗健康投资公司

立即沟通

Par Equity

早期风险投资公司

立即沟通

Scottish Enterprise

苏格兰政府的非部门公共投资机构

立即沟通

产业链接查看更多

所属赛道

专科医院与诊所
互联网+医疗健康
近30天,融资7起 过亿美元融资2起
利用互联网的连接属性,将中国的医疗需求链接到全世界,跨境医疗应该是一条有效的解决途径。当前,中国跨境医疗旅游行业处于起步阶段,现阶段以输出型跨境医疗消费为主。